Dermatology News

Recently published data revealed that the perceptions of patients with psoriasis differ from their dermatologists regarding disease severity, symptoms and happiness with the level of disease control.

Recently published findings revealed that women with rheumatoid arthritis and psoriasis have an increased risk for major adverse cardiac events compared with the general population.

Performing radiologic imaging and blood cultures in patients with suspected cellulitis does not meaningfully aid in the diagnosis or treatment of the condition and is rather costly, according to findings published in JAMA Internal Medicine.

Anti–TNF therapy is effective in patients with ankylosing spondylitis and psoriatic arthritis at 4 months, and becomes progressively more effective during the next 3 years, with a drug retention rate of approximately 60%, according to findings published in the Journal of Clinical Rheumatology.

Self-administered secukinumab was both safe and efficacious, leading to sustained improvements in disease signs and symptoms, among patients with psoriatic arthritis who had not responded to previous first-line therapies, according to findings published in Arthritis Research and Therapy.

The FDA has approved changing the boxed labeling on certolizumab pegol to include data demonstrating a negligible-to-low risk for drug transfer through placenta and a minimal risk for transfer through breast milk among women with chronic inflammatory diseases.

Today, Sun Pharma announced that Ilumya has been approved by the FDA for the treatment of moderate-to-severe plaque psoriasis in adults who are eligible for systemic therapy or phototherapy.

Clinicians should counsel children, their parents and young adults on the use of sun protective behaviors for the prevention of skin cancer, according to a final recommendation statement from the U.S. Preventive Services Task Force.

Primary care pediatricians who utilized an educational program and an electronic medical record ordering tool at the same time were more likely to follow clinical guidelines on acne, according to findings presented at the American Academy of Dermatology annual meeting.

A Best Practice Advisory tool that is part of the EPIC electronic health record system failed to change most primary care physician behaviors when it came to prescribing acne treatments, according to findings presented at the society’s annual meeting.